Clinical Trial Update: A Phase III Trial of Lorenzo's Oil in Adrenomyeloneuropathy [Phase 3]

View source ↗

Summary

Phase III trial of Lorenzo's Oil for adrenomyeloneuropathy and adrenoleukodystrophy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenoleukodystrophy
• Adrenomyeloneuropathy

Drugs mentioned

• Lorenzo's Oil

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Adrenomyeloneuropathy, Adrenoleukodystrophy | Phase 3 | Status: TERMINATED